oral bpc/157 Is BPC-157 Banned? vs. Injectable Forms Explained BPC-157 Double Strength | LVLUP
Description
It is a major actin-sequestering peptide present in virtually all mammalian cells and becomes highly concentrated at injury sites, released by platelets and white blood cells
PMID: 25998928
Medium chain triglyceride formulation comprising transplatin as the therapeutic agent are prepared as described in Example A9 with the exception that the JNK inhibitor is replaced with transplatin
Tan et al., 2015
